Hansoh Pharma, Atomwise launch AI drug discovery collaboration for multiple therapeutic areas
Hansoh Pharmaceutical Group Company, a leading biopharmaceutical company in China, and Atomwise, the leader in artificial intelligence (AI) for drug discovery, have announced a collaboration to design and discover potential drug candidates for up to eleven undisclosed target proteins in multiple therapeutic areas.